Terravia (TVIAQ) vs. Its Rivals Head to Head Comparison
Terravia (OTCMKTS: TVIAQ) is one of 48 publicly-traded companies in the “Specialty Chemicals” industry, but how does it contrast to its peers? We will compare Terravia to similar companies based on the strength of its profitability, analyst recommendations, valuation, institutional ownership, earnings, risk and dividends.
Institutional and Insider Ownership
0.3% of Terravia shares are held by institutional investors. Comparatively, 65.3% of shares of all “Specialty Chemicals” companies are held by institutional investors. 10.1% of Terravia shares are held by insiders. Comparatively, 7.4% of shares of all “Specialty Chemicals” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
This is a breakdown of recent ratings for Terravia and its peers, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Terravia presently has a consensus price target of $1.50, suggesting a potential upside of 27,172.73%. As a group, “Specialty Chemicals” companies have a potential upside of 0.71%. Given Terravia’s higher probable upside, equities research analysts clearly believe Terravia is more favorable than its peers.
This table compares Terravia and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Valuation and Earnings
This table compares Terravia and its peers revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Terravia||$18.48 million||-$101.55 million||0.00|
|Terravia Competitors||$1.91 billion||$115.75 million||220.40|
Terravia’s peers have higher revenue and earnings than Terravia. Terravia is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Volatility & Risk
Terravia has a beta of 1.23, meaning that its stock price is 23% more volatile than the S&P 500. Comparatively, Terravia’s peers have a beta of 1.37, meaning that their average stock price is 37% more volatile than the S&P 500.
Terravia peers beat Terravia on 8 of the 12 factors compared.
Solazyme, Inc. creates renewable oils and bioproducts. The Company’s technology uses microalgae in an industrial fermentation process to transform a range of plant-based sugars into triglyceride oils and other bioproducts. The Company offers Algenist, a skin and personal care product available at Sephora S.A. and its affiliates, QVC, Inc., SpaceNK Limited, select Nordstrom stores and ULTA Beauty. It offers intermediates/ingredients, such as Tailored oils, powdered oils, and other closely related products targeted at customers in the industrial products, food products and personal care products markets. The Company’s commercial focus is to sell oils, encapsulated oils and whole algal powdered products to companies that use them as intermediates and ingredients.
Receive News & Ratings for Terravia Holdings Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terravia Holdings and related companies with MarketBeat.com's FREE daily email newsletter.